Sage Journals: Discover world-class research

Free access

Review article

First published 2014-6

Safety of dipeptidyl peptidase 4 inhibitors: a perspective review

Thomas Karagiannis, Panagiota Boura, Apostolos Tsapas

Therapeutic Advances in Drug Safety

Retricted access

Research article

First published 2016-1

Dipeptidyl Peptidase-4 Inhibitor–Associated Pancreatic Carcinoma

Angela K. Nagel, Nabila Ahmed-Sarwar, Paul M. Werner [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2019-7

Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?

Nordin MJ Hanssen, Karin AM Jandeleit-Dahm

Diabetes & Vascular Disease Research

Retricted access

Case report

First published 2023-8

Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current Evidence

Faten Hadjkacem, Hamdi Frikha, Khouloud Boujelben [...]

Hospital Pharmacy

Retricted access

Research article

First published 2012-11

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis

Haesuk Park, Chanhyun Park, Yoona Kim [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2022-2

Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor–Induced Bullous Pemphigoid

Linli Sun, Chunxia Wang, Cuifang Wu [...]

Annals of Pharmacotherapy

Free access

Brief report

First published 2015-11

Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke

Konstantinos Tziomalos, Stella D Bouziana, Marianna Spanou [...]

Diabetes & Vascular Disease Research

Open access

Review article

First published 2022

Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Katharina Doni, Stefanie Bühn, Alina Weise [...]

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2016

An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease

Devada Singh-Franco, Catherine Harrington, Eglis Tellez-Corrales

Sage Open Medicine

Free access

Research article

First published 2014-3

Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart

Kroekkiat Chinda, Jantira Sanit, Siriporn Chattipakorn [...]

Diabetes & Vascular Disease Research

Search results